James William Kupiec - Net Worth and Insider Trading
James William Kupiec Net Worth
The estimated net worth of James William Kupiec is at least $9,950 dollars as of 2024-11-29. James William Kupiec is the Chief Clinical Dev. Officer of Cassava Sciences Inc and owns about 2,500 shares of Cassava Sciences Inc (SAVA) stock worth over $9,950. Details can be seen in James William Kupiec's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James William Kupiec has not made any transactions after 2022-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James William Kupiec
James William Kupiec Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James William Kupiec owns 1 companies in total, including Cassava Sciences Inc (SAVA) .
Click here to see the complete history of James William Kupiec’s form 4 insider trades.
Insider Ownership Summary of James William Kupiec
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SAVA | Cassava Sciences Inc | 2022-08-23 | Chief Clinical Dev. Officer |
James William Kupiec Latest Holdings Summary
James William Kupiec currently owns a total of 1 stock. James William Kupiec owns 2,500 shares of Cassava Sciences Inc (SAVA) as of August 23, 2022, with a value of $9,950.
Latest Holdings of James William Kupiec
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SAVA | Cassava Sciences Inc | 2022-08-23 | 2,500 | 3.98 | 9,950 |
Holding Weightings of James William Kupiec
James William Kupiec Form 4 Trading Tracker
According to the SEC Form 4 filings, James William Kupiec has made a total of 1 transactions in Cassava Sciences Inc (SAVA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cassava Sciences Inc is the acquisition of 2,500 shares on August 23, 2022, which cost James William Kupiec around $61,100.
Insider Trading History of James William Kupiec
- 1
James William Kupiec Trading Performance
GuruFocus tracks the stock performance after each of James William Kupiec's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James William Kupiec is 32.91%. GuruFocus also compares James William Kupiec's trading performance to market benchmark return within the same time period. The performance of stocks bought by James William Kupiec within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James William Kupiec's insider trading performs compared to the benchmark.
Performance of James William Kupiec
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 65.43 | | | | | |
| Relative Return to S&P 500(%) | 75.98 | | | | | |
James William Kupiec Ownership Network
James William Kupiec Owned Company Details
What does Cassava Sciences Inc do?
Who are the key executives at Cassava Sciences Inc?
James William Kupiec is the Chief Clinical Dev. Officer of Cassava Sciences Inc. Other key executives at Cassava Sciences Inc include SVP & General Counsel Robert Christopher Cook , Chief Financial Officer Eric Schoen , and director & 10 percent owner & CEO & Chairman of the Board Remi Barbier .
Cassava Sciences Inc (SAVA) Insider Trades Summary
Over the past 18 months, James William Kupiec made no insider transaction in Cassava Sciences Inc (SAVA). Other recent insider transactions involving Cassava Sciences Inc (SAVA) include a net purchase of 30,000 shares made by Sanford Robertson , and a net purchase of 18,477 shares made by Richard Barry .
In summary, during the past 3 months, insiders sold 0 shares of Cassava Sciences Inc (SAVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cassava Sciences Inc (SAVA) were sold and 48,477 shares were bought by its insiders, resulting in a net purchase of 48,477 shares.
Cassava Sciences Inc (SAVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cassava Sciences Inc Insider Transactions
James William Kupiec Mailing Address
Above is the net worth, insider trading, and ownership report for James William Kupiec. You might contact James William Kupiec via mailing address: 7801 N Capital Of Texas Highway, Suite 260, Austin Tx 78731.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
